Versartis Inc. | Ownership
Companies that own Versartis Inc.
Baker Bros. Advisors LP
2,426,310
6.7%
1,000,000
0.03%
06/30/2018
The Vanguard Group, Inc.
1,155,644
3.19%
-216,772
0%
06/30/2018
BlackRock Fund Advisors
854,192
2.36%
-1,024,834
0%
06/30/2018
Millennium Management LLC
809,698
2.23%
271,458
0%
06/30/2018
Dimensional Fund Advisors LP
631,061
1.74%
13,359
0%
06/30/2018
Ascend Capital LLC
592,767
1.64%
-31,142
0.05%
06/30/2018
Nexthera Capital LP
500,000
1.38%
500,000
0.2%
06/30/2018
Goldman Sachs & Co. LLC (Private Banking)
328,062
0.91%
103,839
0%
06/30/2018
Renaissance Technologies LLC
292,885
0.81%
230,985
0%
06/30/2018
GSA Capital Partners LLP
284,700
0.79%
125,200
0.02%
06/30/2018
| Address |
1020 Marsh Roade
Menlo Park California 94025
United States
|
|
Employees
|
- |
| Website |
http://www.versartis.com |
| Updated |
09/14/2018 |
| Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. |
